DNAprint Genomics (DNAG)

[worktoplay]

I have told people in several past posts that Kondragunta wasn't listed among the officers in the year end report filed last April...LAST APRIL...There are two others, however, that got promotions. I have posted about that too. Perhaps Dr. Kondragunta was not executive material or didn't fit into the new company structure.

The company is transitioning from Development Stage to Commercial Stage. Does it really surprise you that there would be some personnel moves in the course of that process? Does it really surprise you that some who may have held prominent positions in the past, may have to either adjust to a new reality or leave? Does it really surprise you that those affected might not be too happy about it? Bottom line, that's business boys and girls.

Here it is again for those that missed it the first several times it was posted:

DNAPrint genomics is a consumer oriented genomics company, focused on developing products that enable consumers to utilize the information inherent in their genomes (DNA sequence). Our management team consists of Hector Gomez, MD, Chairman of the Board, Richard Gabriel, CEO/President, Tony Frudakis, Ph.D., CSO, K. Suresh Chandra, Ph.D., Director of Statistical Genomics, and K. Punniswamy, Ph.D., President of Statistical Genomics. The Company believes that these executives have the necessary expertise to make us a leader in the development of genetic tests and products for the consumer genomics marketplace.

This is NOT news to some of us that are paying attention and doing our homework.

Later,
W2P